A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors
Clinical trial NCT01341457 · COMPLETED
Trial details
- NCT number
- NCT01341457
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-06-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.